Meyka Pro banner
Affimed N.V.

Affimed N.V. (AFMDQ) Stock Overview

Explore Affimed N.V.’s financial performance, market position, analyst ratings, and future outlook.

AFMDQPNK
HealthcareBiotechnology
$0.00
$0.00(0.00%)
U.S. Market opens in 19h 41m

Affimed N.V. (AFMDQ)

Meyka AI Score

Z

Key Financials

Market Cap1.6K
P/E Ratio-0.00
EPS (TTM)$-3.61
ROE-1.01%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

AFMDQ Stock Analysis & Investment Overview (PNK)

Our AI-powered analysis of Affimed N.V. (PNK: AFMDQ) gives investors deep insight into how the stock performs on the PNK exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Affimed N.V.'s PNK-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AFMDQ on the PNK shows an RSI of 39.09, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the PNK listing.

Key metrics behind Affimed N.V.'s PNK-traded stock include a P/E ratio of -0.00 and a market capitalization of 1.6K. Combined with our AI analysis, these give both institutional and retail investors a clear view of AFMDQ on the PNK.

Price Performance (PNK: AFMDQ)

1-Day Change
N/A
5-Day Change
9900.00%
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-80.00%
Year-to-Date (YTD) Change
0.00%
1-Year Change
-99.50%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

49 621 560030
Gottlieb-Daimler-Straße 2, Mannheim, BW, 68165

Company Facts

760 Employees
IPO DateSep 12, 2014
CountryDE
Actively Trading

Frequently Asked Questions